chrisvoncsefalvay/vaers-outcomes huggingface dataset:
extreme dizziness since getting the dose; eyelids are swelling & face; eyelids are swelling & face; This spontaneous case was reported by a consumer and describes the occurrence of DIZZINESS (extreme dizziness since getting the dose), EYELID OEDEMA (eyelids are swelling & face) and SWELLING FACE (eyelids are swelling & face) in a  patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     Previously administered products included for Product used for unknown indication: Janssen (Patient took J and J as primary vaccine.). Past adverse reactions to the above products included No adverse event with Janssen.    On an unknown date, the patient received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced DIZZINESS (extreme dizziness since getting the dose), EYELID OEDEMA (eyelids are swelling & face) and SWELLING FACE (eyelids are swelling & face). At the time of the report, DIZZINESS (extreme dizziness since getting the dose) outcome was unknown and EYELID OEDEMA (eyelids are swelling & face) and SWELLING FACE (eyelids are swelling & face) had not resolved.            Concomitant and treatment medication was not provided.   Reporter did not allow further contact
Fever as high as 101?,  myalgia, malaise, pain at injection site, lightheadedness, some arthralagia in wrists and fingers, fatigue,  headache symptoms resolved after about 36 hours
Pruritic, raised bumps on bilateral legs with a "mosquito bite" appearance. Patient has applied Neosporin and antiseptic which has helped relieve symptoms somewhat, went to MD with no new orders. I recommended for patient to see dermatologist. Follow up on 4/8/21- spoke with patient she stated the bumps are still there but definitely getting better than before. Recommended if she experiences any itchiness that she can apply Benadryl cream or hydrocortisone cream. Overall patient is better.
Fatigued, muscle aches, joint aches, body aches, fever, chills, hot flashes, headache, feeling of being in a fog, about 1-2 inches below injection site I have had pain, severe redness & swelling that continues to get larger and is beginning wrap around my arm.
Red raised patches (hives) appeared 36 hrs p/vax given lasting 4 days; also ran low grade temp <102 x 4 days; pt also fussy & spitting up milk more;
In mouth:  Ulcers on tongue, blisters and ulceres on gums/cheeks, bleeding gums, burning gums, mouth odor
This is a spontaneous report from a contactable pharmacist via a Pfizer sales representative. A female patient is in her 50s of an unspecified age and ethnicity received PREVNAR 13 for protection against pneumococcal pneumonia at single dose for immunization on unknown date. The patient was also on an immunodepressive medication. On unknown date the patient the patient experienced a rash on the left side of her body and swelling of her left arm and down the left side of her body. The outcome of the events was recovered.
After 20 minutes face and neck bright red, heartbeat flippy, intchy throat tight lungs, colon completely evacuated.
Headache, Sedation, Myalgia, Fever, NauseaVomiting, chills and fatigue. pain, redness, and swelling at the injection site.  Narrative:
Sore Left Arm  day/night of injection resolved next day Extreme Fatigue day of and next day after injection resolved third day
This spontaneous report as received from a registered nurse via Medical Record refers to a 13 months old female patient with no known drug allergies (NKDA). The patient's current conditions included: gastro esophageal reflux disease (GERD) and umbilical hernia. On 17-MAR-2013, the patient was vaccinated with the first dose of hepatitis B virus vaccine (unspecified) for Hep B. On 22-MAY-2013, the patient was vaccinated with the first dose of PEDIARIX for DTP/aP; First dose of ACTHIB; First dose of PREVNAR 13 for PCV; First dose of ROTARIX for Rotavirus. On 19-JUL-2013, the patient was vaccinated with the second dose of DAPTACEL for DTP/aP; second dose of ACTHIB for Hib; Second dose of PREVNAR for PCV; Second dose of ROTARIX for Rotavirus. On 26-SEP-2013, the patient was vaccinated with the third dose of PEDIARIX for DTP/aP; third dose of ACTHIB; Third dose of PREVNAR 13 for PCV;On 17-JAN-2014, the patient was vaccinated with the First dose of FLUZONE-PF for influenza; Third dose of IPOL for Polio. On 24-MAR-2014 at 09:45 am, the patient was vaccinated with the first dose of PROQUAD (Merck) (lot # J015312, expiry date: 03-JUN-2013) (dose and route of administration not reported) which was stored improperly, exposed to 42F for 4 weeks. It was reported that the patient did not seek medical attention. On the same date, the patient was vaccinated with the first dose of HAVRIX for HepA; Second dose of FLUZONE-PF for influenza; Fourth dose of PREVNAR 13 for PCV and VARIVAX (Merck) for Varicella (dose and lot # not reported). On 28-APR-2014, the patient was vaccinated with PEDVAXHIB for Hib. This is one of several reports from the same source. Pediatric medical records were received and reviewed; no adverse experience related to the prenatal exposure or to other Merck Products. were identified. All available medical records will be provided upon request. Additional information is not expected.
I was very dizzy when I woke up on 3/18/2021 (one week after my first dose) and on 3/19/2021.  The dizziness lasted for about 20 minutes.  I have also been feeling generally fatigued.  On 3/29/2021 I felt so fatigued that I took a sick day off from work.  For all three events, I felt normal by mid-morning.
The Pfizer (maroon cap) vaccine was administered to this patient who is 3 years old. However, the nurse used the incorrect volume of diluent to reconstitute the vaccine vial. 1.3ml of sodium chloride was used for reconstitution instead of the required 2.2mL for the maroon cap vaccine. The patient was given the vaccine and monitored during the observational phase. No adverse event was seen.  Contacted Pfizer representative for more information regarding future vaccination schedule. Pfizer representative stated that the patient should just continue the vaccination schedule normally as indicated by the CDC guidelines.
This spontaneous report as received from a physician refers to a 6 month old patient. On 16-JUN-2014, the patient was vaccinated with an expired 0.5 ml dose of RECOMBIVAX HB (Lot # 1625AA, expiration date 06-JUN-2014) (route not reported). No adverse events were reported. Additional information is not expected.
Fever, chills, frequent vomiting. I experienced severe arm pain at the injection side (on the right), also breast pain on the right side
I had constipation that latest about a week. I also have ongoing constipation for several months. I went to see my provider in December 2021. Then I had a coloscopy recently in December 2022 and the results are still pending. Also inflammation.
Chills with tremors, then fever with sweating, stomach pain, nauscious (spelling?) upon sitting up, dizzy when sitting up or attempting to walk and feeling that I had to throw up, continued till next day until about 8:30 pm. I slept well that night (Saturday).  Still nauscious  Sunday and dizzy and stomach pain that continued through Monday.  Tuesday still light - headed and weak.  Also had headache through Monday.  Not sure I am through the whole thing yet.
No probs at time of immunization. No localized reaction. Per mom fever (unknown how hig)-restless, screaming, whimpering the next day. Previous shots at 1 yr did also (different immunizations-DTaP, varicella, Comvax at that time).
THIS R.N. SINCE THE TIME OF THE INFLUENZA INJECTION HAS HAD A LARGE DIMPLE IN HER ARM WHICH HAS CONTINUED TO ITCH.
deltoid area of my left arm is very tight and achy; deltoid area of my left arm is very tight and achy; arm and shoulder mobility is limited some; arm and shoulder mobility is limited some; experiencing GERD symptoms; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.An adult male patient received BNT162b2 (BNT162B2), on 19Nov2021 as dose 3 (booster), single (Lot number: FH8C25) at the age of 63 years intramuscular, in left arm for covid-19 immunisation. The patient's relevant medical history included: "Elevated cholesterol" (unspecified if ongoing); "cardiovascular (valve murmur; RBBB)" (unspecified if ongoing); "low grade prostate CA diagnosis" (unspecified if ongoing); "cardiovascular (valve murmur; RBBB)" (unspecified if ongoing); "RBBB" (unspecified if ongoing). Concomitant medication(s) included: CRESTOR; LOVAZA. Past drug history included: Amoxicillan, reaction(s): "Allergy". Vaccination history included: pfizer (product=COVID 19, brand=Pfizer,, lot number=EP6955,, route=Intramuscular, dose administration date=01Apr2021, dose dose number=2, dose vaccine location=Left arm,), administration date: 01Apr2021, when the patient was 63-year-old, for COVID-19 immunization; pfizer (dose product=COVID 19, dose brand=Pfizer, lot number=EL3247, route=Intramuscular, dose administration date=11Mar2021, dose number=1, dose vaccine location=Left arm), administration date: 11Mar2021, when the patient was 63-year-old, for COVID-19 immunization.The following information was reported: MOBILITY DECREASED (non-serious), JOINT RANGE OF MOTION DECREASED (non-serious) all with onset Mar2022, outcome "not recovered" and all described as "arm and shoulder mobility is limited some"; VACCINATION SITE PAIN (non-serious), INJECTION SITE DISCOMFORT (non-serious) all with onset Mar2022, outcome "not recovered" and all described as "deltoid area of my left arm is very tight and achy"; GASTROOESOPHAGEAL REFLUX DISEASE (non-serious) with onset Mar2022, outcome "not recovered", described as "experiencing GERD symptoms". Therapeutic measures were not taken as a result of vaccination site pain, injection site discomfort, mobility decreased, joint range of motion decreased, gastrooesophageal reflux disease. Additional Information: Patient didn't receive other vaccine in four weeks. Prior to the vaccination, the patient was not diagnosed with COVID-19.  Since the vaccination, the patient had not been tested for COVID-19. Beginning about 3-4 months after 3rd vaccination - starting to notice intermittently. Upon waking in the morning from sleep, notice the deltoid area of my left arm is very tight and achy. At times arm and shoulder mobility is limited some. All gradually improves as I start moving for the day and showering, but takes some time to resolve. Do not notice this during the day. In addition, starting about the same timeframe, I am now experiencing GERD symptoms which I have not had in my entire life.
Per child's mother. Child had a reaction to vaccine injection site. Child was taken to Urgent Care to be evaluated. Per mother child was placed on antibiotics for infection to injection site. Mother states (today) child has been on antibiotics for approx. 2 days and is doing better.
This spontaneous report as received from a pharmacy intern refers to an adult patient of unknown age and gender. The patient's current conditions, pertinent medical history, drug reactions/allergies and concomitant medications were not reported. On 01-AUG-2017 the patient was vaccinated with a pediatric dose of RECOMBIVAX HB (strength 2.5/0.5) (dose, lot/batch# and expiration date were not reported) by accident instead of an adult dose (drug administered to patient of inappropriate age) intramuscularly for prophylaxis. No adverse effects were reported. No product quality complaint(PQC) involved. The outcome of drug administered to patient of inappropriate age and no adverse effects was unknown.
"woke up this morning and felt dizzy and almost fell."; This spontaneous case was reported by a consumer and describes the occurrence of DIZZINESS ("woke up this morning and felt dizzy and almost fell.") in a 73-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 026A21A) for COVID-19 vaccination.     No medical history was provided by the reporter.  Concomitant products included VERAPAMIL, ATORVASTATIN, ALPRAZOLAM, INSULIN ASPART (NOVOLOG), ACETYLSALICYLIC ACID (ASPIRIN (E.C.)), VITAMIN D NOS, PANTOPRAZOLE and TETRABENAZINE (TETRAZIN [TETRABENAZINE]) for an unknown indication.    On 18-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 25-Mar-2021, the patient experienced DIZZINESS ("woke up this morning and felt dizzy and almost fell."). At the time of the report, DIZZINESS ("woke up this morning and felt dizzy and almost fell.") outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   Other concomitant medications include Lantus every night, HCT Lisinipril 20mg daily, hyrdolizine hcl daily for an unknown indication. No treatment information was provided.
Flu; Did not get the 2nd dose / Greater than 42 days after first dose; This spontaneous case was reported by a consumer and describes the occurrence of INFLUENZA (Flu) and PRODUCT DOSE OMISSION ISSUE (Did not get the 2nd dose / Greater than 42 days after first dose) in a 48-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 002F21A) for COVID-19 vaccination.     No Medical History information was reported.    On 24-Aug-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced INFLUENZA (Flu) and PRODUCT DOSE OMISSION ISSUE (Did not get the 2nd dose / Greater than 42 days after first dose). At the time of the report, INFLUENZA (Flu) outcome was unknown and PRODUCT DOSE OMISSION ISSUE (Did not get the 2nd dose / Greater than 42 days after first dose) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   No Concomitant medication reported.  The patient experienced flu (confirmed as not COVID disease). It was reported that the patient did not take the 2nd dose and stated that had to restart the series as per physician recommendation.  No Treatment medication reported.
Both arms hurting after the second dose of COVID vaccine; This is a spontaneous report from a contactable consumer. A female patient of an unspecified age received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE), dose 2 as single dose for covid-19 immunisation.  The patient medical history and concomitant medications were not reported. Caller states that her daughter had the same experience with both arms hurting after the second dose of COVID vaccine. She says it was the same vaccine as she had. Outcome was unknown.   No follow-up attempts are possible; information about lot/batch number cannot be obtained.
muscle weakness on one side of her face; On 06Jan2021 I suddenly have tingling and muscle weakness on one side of my face.; This is a spontaneous report from a contactable other healthcare professional (patient). A 33-year-old female patient received her first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, Lot number=eh9899), intramuscularly on left arm at 07:15 AM on 21Dec2020 at single dose for COVID-19 immunization. Medical history included high blood pressure and asthma, no allergies to medications, food, or other products. Concomitant medication included lisinopril and non-hormone birth control. The patient suddenly had tingling and muscle weakness on one side of her face at 07:30 AM on 06Jan2021. All events were reported as non-serious. The patient did not receive any treatment from events. Prior to vaccination, the patient was not diagnosed with COVID-19; Since the vaccination, the patient had not been tested for COVID-19. The outcome of events was not recovered.
High fever-went to ER (blood cx, uring dip and CBC). Given antibiotic injection next day at office visit. Not known if positive reaction.
Narrative:  COVID infection following COVID vaccine series 09/30, Pfizer, dose #1 10/21, Pfizer, dose #2 09/28 pt admit to medicine cc: shortness of breath dx: Community Acquired pneumonia LOS: 1 day 09/28 CXR impression: Multifocal pneumonia. Continued follow-up after treatment.  11/03 CXR impression: Multifocal consolidations have improved. There is a small amount of residual hazy opacity in the right lung base. The cardiac and mediastinal silhouettes are within normal limits. No pleural effusion or pneumothorax. 11/09 CXR impression: New findings of mediastinal interstitial pulmonary edema since 6 days ago, in keeping with congestive heart failure. This would account for the patient's dyspnea. Bilateral pleural effusions, RIGHT larger than LEFT, increased in volume since 11/3/2021. 11/05 pt cc: dyspnea, cough exposure: unknown 11/09 COVID swab, result: detected 11/10 COVID swab, result: detected 11/15 pt admit to medicine cc: SOB dx: Acutely decompensated systolic HF LOS: 5 days
I had sore throat, drainage, head congestion, tickled cough, fatigue, and headache. I tested positive for COVID-19 at home. My doctor prescribed me PAXLOVID. It took another 48 hours after I started feeling better. I still have a cough, headache, drainage, and fatigue. The symptoms are getting better everyday.
dizziness, chills, nausea and vomiting, headache,  weakness and pain in the arm/injection site.
Fatigue,  Weakness in legs, Leg Muscles, Pain in Bones, Neuropathy 3 times worse, .Knees very Painful, hard to sleep
Uncontrolled seizures to date, 2002. Severe brain damage, development delayed with cog, motor, speech and intellect; severe impairment with severe permanent damage. Annual follow up states pt has not recovered. Severe development delay, speech and cong. delay. Brain damage and uncontrolled seizure disorder. Follow up 2/25/05: Review images, pt should have same info as reporter (parent) who submitted new address and phone number as follow up.  36 hrs after admin of DPT, Pt seizes, eyes flutter, mouth twitching, unresponsive states, paramedics called 2x's, ER visits to follow, neuron visits to follow immediately. Referred childrens for care, treatments? Scared docs who knew what happened but were to afraid to step up and help/admit what in fact happened. Today she is severely brain damaged with uncontrolled seizures. On seizure meds since age 3 due to the mothers insistence and constant fight for help/treatment and to look beyond the denial. She is functioning at an age level of about 3-4. A 'Sacrifice' to ensure vaccine safety she is.
Presented to office 6/4/12 with full body rash, raised red bumps (12 days post immunizations), fever 102 degrees. Yesterday, "orange sized" lump (L) thigh that is decreased in size today.
I was pretty sick the day after - fever, severe headache and chills. That started in the first evening of April 9th and all day the 10th. On April 11 the chills and fever went away. I had a shooting headache  - for a few minutes and sometimes just for a few seconds then it would go away and that continued until the 12th. . And that kept happening for about 5 days or so. Leg pain happened on the 19th - no swelling. It got really uncomfortable and I couldn't sleep at night. I went to the doctor and he did just a visual and physical pushing etc - he thought it was nerve pain. It subsided after quite a bit after 3 days and was gone by a week.
This spontaneous case was reported by a nurse and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (606 doses were given after expiration date) in a 29-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 043B21A) for COVID-19 vaccination. No Medical History information was reported. On 05-Nov-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 05-Nov-2021, the patient experienced EXPIRED PRODUCT ADMINISTERED (606 doses were given after expiration date). At the time of the report, EXPIRED PRODUCT ADMINISTERED (606 doses were given after expiration date) outcome was unknown. For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments. No concomitant medications were reported. The vial was placed in refrigerator on 04-Nov-2021. Vial did not undergone to any temperature excursion. No adverse event was reported. No treatment medications were reported. This case was linked to MOD-2022-491837 (Patient Link).
Warm in injection site; Swelling of lymph nodes; redness in injection site; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE WARMTH (Warm in injection site), LYMPHADENOPATHY (Swelling of lymph nodes) and VACCINATION SITE ERYTHEMA (redness in injection site) in a 65-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 002B21A) for COVID-19 vaccination.     Concurrent medical conditions included Thyroid disorder NOS. Concomitant products included THYROID and ROSUVASTATIN CALCIUM (CRESTOR) for an unknown indication.   On 13-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 11-Apr-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 14-Mar-2021, the patient experienced VACCINATION SITE WARMTH (Warm in injection site), LYMPHADENOPATHY (Swelling of lymph nodes) and VACCINATION SITE ERYTHEMA (redness in injection site). On 29-Mar-2021, VACCINATION SITE WARMTH (Warm in injection site), LYMPHADENOPATHY (Swelling of lymph nodes) and VACCINATION SITE ERYTHEMA (redness in injection site) had resolved.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   No treatment medication details was reported.
shortness of breath; tightness in throat; sore throat; chills; cough; fatigue; runny nose; chest congestion; This is a spontaneous report from a contactable other healthcare professional (patient). A 72-years-old female patient received second dose of bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, Formulation: Solution for injection, Batch/Lot Number: EZ9262, via an unspecified route of administration, in arm left on 06Feb2021 at 09:30 (at 72-years age), as dose 2, single for covid-19 immunisation. The patient medical history and concomitant medications were not reported. She previously took first dose of bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, Formulation: Solution for injection, Lot Number: 1284, 72-years-old at the time of vaccination), via an unspecified route of administration, in arm left on 16Jan2021 as single for covid-19 immunisation and experienced redness and swelling at injection site no other side effects. On 07Feb2021 the patient underwent blood test, chest X-RAY and electrocardiogram which resulted normal. On 07Feb2021, the patient experienced shortness of breath, tightness in throat, sore throat, chills, cough, fatigue, runny nose. Adverse events required visit to emergency room. On an unknown date in Feb2021 she experienced chest congestion. Patient took cough medicine for mucus and chest congestion vicks on chest and heat pad and did not receive any treatment for all other events. Outcome was unknown for chest congestion and was resolved with sequel on 09Feb2021 for all other events.  No follow-up attempts are possible. No further information is expected.